rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies

NCT02710500 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
2
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sarepta Therapeutics, Inc.